Menu
GeneBe

15-27532602-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 4P and 2B. PM2PP5_ModerateBP4BP7

The NM_033223.5(GABRG3):c.1125C>T(p.Asn375=) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★).

Frequency

Genomes: not found (cov: 32)

Consequence

GABRG3
NM_033223.5 splice_region, synonymous

Scores

2

Clinical Significance

Pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 1.16
Variant links:
Genes affected
GABRG3 (HGNC:4088): (gamma-aminobutyric acid type A receptor subunit gamma3) This gene encodes a gamma-aminobutyric acid (GABA) receptor. GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. GABA-A receptors are pentameric, consisting of proteins from several subunit classes: alpha, beta, gamma, delta and rho. The protein encoded by this gene is a gamma subunit, which contains the benzodiazepine binding site. Two transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Aug 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 15-27532602-C-T is Pathogenic according to our data. Variant chr15-27532602-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 870529.Status of the report is criteria_provided_single_submitter, 1 stars.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).. Strength limited to SUPPORTING due to the PP5.
BP7
Synonymous conserved (PhyloP=1.16 with no splicing effect.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GABRG3NM_033223.5 linkuse as main transcriptc.1125C>T p.Asn375= splice_region_variant, synonymous_variant 10/10 ENST00000615808.5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GABRG3ENST00000615808.5 linkuse as main transcriptc.1125C>T p.Asn375= splice_region_variant, synonymous_variant 10/101 NM_033223.5 P1Q99928-1
ENST00000556642.1 linkuse as main transcriptn.85+8511G>A intron_variant, non_coding_transcript_variant 2
GABRG3ENST00000333743.10 linkuse as main transcriptc.588C>T p.Asn196= splice_region_variant, synonymous_variant 7/75

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Angelman syndrome Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingKamineni Academy of Medical Sciences & Research Centre, Kamineni HospitalsMar 08, 2020The GABRG3 1125C>T was identified in a 9 year/female who has developmental delay, microcephaly, gait ataxia, absent speech and behavioral issues. She was subjected to Chromosomal microarray (CMA) and exome sequencing. CMA reported multiple absence of heterozygosity regions with 15q11.2 being the primary. Methylation studies indicated both the parental alleles to be present ruling out Angelman syndrome by imprinting defects. Raw data of CMA and exome were assessed and the reported variant was a single heterozygous change in the long stretch of 7 mb absence of heterozygosity region. Genes associated with phenotype were also analysed for possible differential diagnoses, however, no clinically significant changes were observed. Reported variant is novel and was identified to be damaging by in silico analysis. Segregation in parents and normal healthy siblings revealed it is de novo. The condition is Angelman like, since the gene is in the AS-PWS critical region, GABRG3 should be evaluated in individuals with AS features but with a negative UBE3A mutation status -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
Cadd
Benign
11
Dann
Benign
0.80

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1891450501; hg19: chr15-27777748; API